E-mail

E-mail a Wiley Online Library Link

C. Mamolo, J. Harness, H. Tan and A. Menter Tofacitinib (CP-690,550), an oral Janus kinase inhibitor, improves patient-reported outcomes in a phase 2b, randomized, double-blind, placebo-controlled study in patients with moderate-to-severe psoriasis Journal of the European Academy of Dermatology and Venereology 28

Version of Record online: 7 JAN 2013 | DOI: 10.1111/jdv.12081

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field

SEARCH